EU: Regulation (EC) No 1907/2006 of The European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94, as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJEU. 2006, L396: 1-843. (EC 1907/2006)
Google Scholar
NRC: Toxicity Testing in the 21st Century: A Vision and a Strategy. 2007, National Academy Press, Washington, DC
Google Scholar
FDA: Critical Path Initiative. 2010, US Department of Health and Human Services, Rockville, MD, (accessed 15th June, 2010), [http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/default.htm]
Google Scholar
FDA: Challenge and opportunity on the critical path to new medical products. 2004, US Department of Health and Human Services, US Food and Drug Administration, Rockville, MD, [http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm()77262.htm]
Google Scholar
Yang C, Valerio LG, Arvidson KB: Computational toxicology approaches at the US Food and Drug Administration. Altern Lab Anim. 2009, 37: 523-531.
CAS
PubMed
Google Scholar
Valerio LG: In silico toxicology for the pharmaceutical sciences. Toxicol Appl Pharmacol. 2009, 241: 356-370. 10.1016/j.taap.2009.08.022.
Article
CAS
PubMed
Google Scholar
Valerio LG, Arvidson KB, Busta E, Minnier BL, et al: Testing computational toxicology models with phytochemicals. Mol Nutr Food Res. 2010, 54: 186-194. 10.1002/mnfr.200900259.
Article
CAS
PubMed
Google Scholar
Valerio LG: Tools for evidence-based toxicology: Computational-based strategies as a viable modality for decision support in chemical safety evaluation and risk assessment. Hum Exp Toxicol. 2008, 27: 757-760. 10.1177/0960327108097689.
Article
CAS
PubMed
Google Scholar
Valerio LG, Yang C, Arvidson KB, Kruhlak NL: A structural feature-based computational approach for toxicology predictions. Expert Opin Drug Metab Toxicol. 2010, 6: 505-518. 10.1517/17425250903499286.
Article
CAS
PubMed
Google Scholar
Valerio LG, Arvidson KB, Busta E, Minnier BL, et al: Testing computational toxicology models with phytochemicals. Mol Nutr Food Res. 2010, 54: 186-194. 10.1002/mnfr.200900259.
Article
CAS
PubMed
Google Scholar
Valerio LG: Computational science in drug metabolism and toxicology. Expert Opin Drug Metab Toxicol. 2010, 6: 781-784. 10.1517/17425255.2010.486789. [Editorial]
Article
CAS
PubMed
Google Scholar
Evers A, Klebe G: Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model. J Med Chem. 2004, 47: 5381-5392. 10.1021/jm0311487.
Article
CAS
PubMed
Google Scholar
Combes RD: Is computational toxicology withering on the vine?. Arch Toxicol. 2010, 84: 333-336. 10.1007/s00204-010-0528-6.
Article
CAS
PubMed
Google Scholar
Johnson SR: The trouble with QSAR (or how I learned to stop worrying and embrace fallacy). J Chem Inf Model. 2007, 48: 25-26.
Article
PubMed
Google Scholar
Greene N, Naven R: Early toxicity screening strategies. Curr Opin Drug Discov Devel. 2009, 12: 90-97.
CAS
PubMed
Google Scholar
Merlot C: Computational toxicology -- A tool for early safety evaluation. Drug Discov Today. 2010, 15: 16-22. 10.1016/j.drudis.2009.09.010.
Article
CAS
PubMed
Google Scholar
Boyer S: The use of computer models in pharmaceutical safety evaluation. Altern Lab Anim. 2010, 37: 467-475.
Google Scholar
FDA: Draft guidance for industry: Genotoxic and carcinogenic impurities in drug substances and products: Recommended approaches. 2008, US FDA/CDER, US Department of Health and Human Services, Silver Spring, MD
Google Scholar
Naven RT, Louise-May S, Greene N: The computational prediction of genotoxicity. Expert Opin Drug Metab Toxicol. 2010, 6: 797-807. 10.1517/17425255.2010.495118.
Article
CAS
PubMed
Google Scholar
Benigni R, Bossa C, Tcheremenskaia O, Giuliani A: Alternatives to the carcinogenicity bioassay In silico methods, and the in vitro and in vivo mutagenicity assays. Expert Opin Drug Metab Toxicol. 2010, 6: 809-819. 10.1517/17425255.2010.486400.
Article
CAS
PubMed
Google Scholar
Benigni R, Bossa C: Predictivity and reliability of QSAR models: The case of mutagens and carcinogens. Toxicol Mech Methods. 2008, 18: 137-147. 10.1080/15376510701857056.
Article
CAS
PubMed
Google Scholar
Lee N, Authier S, Pugsley MK, Curtis MJ: The continuing evolution of torsades de pointes liability testing methods: Is there an end in sight?. Toxicol Appl Pharmacol. 2010, 243: 146-153. 10.1016/j.taap.2009.12.002.
Article
CAS
PubMed
Google Scholar
Roden DM: Drug-induced prolongation of the QT interval. N Engl J Med. 2004, 350: 1013-1022. 10.1056/NEJMra032426.
Article
CAS
PubMed
Google Scholar
Piccini JP, Whellan DJ, Berridge BR, Finkle JK, et al: Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the Critical Path Initiative. Am Heart J. 2009, 158: 317-326. 10.1016/j.ahj.2009.06.007.
Article
PubMed
Google Scholar
FDA: International Conference on Harmonisation: Guidance on E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs; availability. 2005, 70: 61134-61135. Notice. Department of Health and Human Services
Google Scholar
Cavero I, Crumb W: ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: A critical analysis. Expert Opin Drug Saf. 2005, 4: 509-530. 10.1517/14740338.4.3.509.
Article
PubMed
Google Scholar
Cartwright ME, Petruska J, Arezzo J, Frank D, et al: Phospholipidosis in neurons caused by posaconazole, without evidence for functional neurologic effects. Toxicol Pathol. 2009, 37: 902-910. 10.1177/0192623309348521.
Article
CAS
PubMed
Google Scholar
Kruhlak NL, Choi SS, Contrera JF, Weaver JL, et al: Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicol Mech Methods. 2008, 18: 217-227. 10.1080/15376510701857262.
Article
CAS
PubMed
Google Scholar
FDA: The regulatory challenges of drug-induced phospholipidosis. 2010, Department of Health and Human Services, Bethesda, MD, (accessed 14th June, 2010), [http://www.fda.gov/downloads/AdvisoryCommittees/Committees.MeetingMaterials/Drugs/AdvisoryCommitteeforPharmaceuticalScienceandClinicalPharmacology/UCM210798.pdf]
Google Scholar
NAMS. The North American Menopause Society web page: Hormone therapy statistics. 2010, NAMS, Mayfield Heights, OH, (accessed 15th May, 2010), [http://www.menopause.org/hormone-therapystats.aspx]
Google Scholar
Kurzer MS, Xu X: Dietary phytoestrogens. Ann Rev Nutr. 1997, 17: 353-381. 10.1146/annurev.nutr.17.1.353.
Article
CAS
Google Scholar
Liu J, Burdette JE, Xu H, Gu C, et al: Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem. 2001, 49: 2472-2479. 10.1021/jf0014157.
Article
CAS
PubMed
Google Scholar
Lieberman S: A review of the effectiveness of Cimicifuga race-mosa (black cohosh) for the symptoms of menopause. J Women's Health. 1998, 7: 525-529. 10.1089/jwh.1998.7.525.
Article
CAS
Google Scholar
Mahady GB, Dog TL, Barrett ML, Chavez ML, et al: United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause. 2008, 15: 628-638. 10.1097/gme.0b013e31816054bf.
Article
PubMed
Google Scholar
Betz J, Anderson L, Avigan MI, Barnes J, et al: Black cohosh. Considerations of safety and benefit. Nutr Today. 2009, 44: 155-162. 10.1097/NT.0b013e3181af63f9.
Article
Google Scholar
Wang WJ, Dou J, Cross KP, Valerio LG: Computational analysis for hepatic safety signals of constituents present in botanical extracts widely used by women in the United States for treatment of menopausal symptoms. Reg Toxicol Pharmacol. 2011, 59: 111-124. 10.1016/j.yrtph.2010.09.012.
Article
Google Scholar
Valerio LG: The in silico prediction of human-specific metabolites from hepatotoxic drugs. Curr Drug Discov Technol. 2010, 7: 170-187.
CAS
PubMed
Google Scholar